» Articles » PMID: 8675223

Agalactosyl IgG and Beta-1,4-galactosyltransferase Gene Expression in Rheumatoid Arthritis Patients and in the Arthritis-prone MRL Lpr/lpr Mouse

Overview
Journal Immunology
Date 1996 Apr 1
PMID 8675223
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Reduced galactosylation of immunoglobulin G (IgG) is well documented in rheumatoid arthritis (RA), but the reason for this defect is still unknown. There is some evidence supporting a defect in the biosynthetic pathway, and a reduction in the level of beta-1,4-galactosyltransferase (beta-1,4-GalTase) enzyme activity. Since glycosyltransferases are, in general, regulated at the level of transcription, we have measured the level of beta-1,4-GalTase gene expression in B cells from patients with RA and normal control individuals. We found no significant difference in mRNA levels for the transferase in these two groups (P > 0.7). MRL/Mp-lpr/lpr (MRL-lpr) mice develop a spontaneous arthritis with increased levels of agalactosyl IgG (G0). In spite of a significant reduction in the level of beta-1,4-GalTase mRNA in total spleen lymphocytes from MRL-lpr mice compared with the congenic MRL/Mp-(+/+) (MRL-(+/+) mice and with CBA/Ca mice, we found comparable levels of the beta-1,4-GalTase mRNA in purified B cells from both spleen and lymph nodes of the three strains. Amongst the lymphoid compartments examined, the spleen and peripheral blood were found to be the major contributors of G0 in MRL-lpr mice. These data indicate that in neither human RA, nor in an animal model of this disease, is reduced IgG galactosylation caused by impaired expression of the beta-1,4-GalTase gene in B lymphocytes. Furthermore, splenic B cells, which have normal levels of beta-1,4-GalTase mRNA, appear to be a major source of G0 in MRL-lpr mice.

Citing Articles

Estrogen-Driven Changes in Immunoglobulin G Fc Glycosylation.

Lagattuta K, Nigrovic P Exp Suppl. 2021; 112:341-361.

PMID: 34687016 DOI: 10.1007/978-3-030-76912-3_11.


Immunoglobulin G Glycosylation Changes in Aging and Other Inflammatory Conditions.

DallOlio F, Malagolini N Exp Suppl. 2021; 112:303-340.

PMID: 34687015 DOI: 10.1007/978-3-030-76912-3_10.


Exome Sequencing Identifies Abnormalities in Glycosylation and ANKRD36C in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura.

Basu M, Massicano F, Yu L, Halkidis K, Pillai V, Cao W Thromb Haemost. 2020; 121(4):506-517.

PMID: 33184803 PMC: 8091491. DOI: 10.1055/s-0040-1719030.


Identification of novel plasma glycosylation-associated markers of aging.

Catera M, Borelli V, Malagolini N, Chiricolo M, Venturi G, Reis C Oncotarget. 2016; 7(7):7455-68.

PMID: 26840264 PMC: 4884931. DOI: 10.18632/oncotarget.7059.


The effect on immunoglobulin glycosylation of altering in vivo production of immunoglobulin G.

Jeddi P, Keusch J, Lydyard P, Bodman-Smith K, Chesnutt M, Wofsy D Immunology. 1999; 98(3):475-80.

PMID: 10583610 PMC: 2326953. DOI: 10.1046/j.1365-2567.1999.00896.x.


References
1.
Katagiri T, Mori T, Nakano T, Ueno K, Kano K . Aberrant expression of Forssman and Paul-Bunnell antigens on lymph node cells of MRL/Mp-lpr/lpr mice. J Immunol. 1984; 133(6):3143-8. View

2.
Keusch J, Lydyard P, Isenberg D, Delves P . beta 1,4-Galactosyltransferase activity in B cells detected using a simple ELISA-based assay. Glycobiology. 1995; 5(4):365-700. DOI: 10.1093/glycob/5.4.365. View

3.
Shields J, Turner M . The importance of antibody quality in sandwich ELISA systems. Evaluation of selected commercial reagents. J Immunol Methods. 1986; 87(1):29-33. DOI: 10.1016/0022-1759(86)90340-6. View

4.
Shaper N, Shaper J, Bertness V, Chang H, Kirsch I, Hollis G . The human galactosyltransferase gene is on chromosome 9 at band p13. Somat Cell Mol Genet. 1986; 12(6):633-6. DOI: 10.1007/BF01671948. View

5.
Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162(1):156-9. DOI: 10.1006/abio.1987.9999. View